An experimental Alzheimer's drug shows some promise as researchers hunt new approaches - AP News
- An experimental Alzheimer's drug shows some promise as researchers hunt new approaches AP News
- Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease Biogen
- Biogen Alzheimer's drug slowed decline at rates on par with approved therapies, study shows STAT
- AAIC: Biogen bolsters hopes for Alzheimer's pivotal push as anti-tau oligo slows cognitive decline Fierce Biotech
- A Drug Already Proven Safe in Humans Just Reduced Multiple Signs of Alzheimer's in Mice ScienceAlert
Related Markets
All MarketsMarket data may be delayed. Not financial advice.
💡 AI analysis provides alternative perspectives on current events